Lazaz-M

Lazaz-M is a combination oral tablet developed and marketed by MetaneX Life Science, primarily used for the treatment of respiratory conditions such as asthma, allergic rhinitis, and bronchospasms. It contains two active ingredients: levocetirizine and montelukast. Levocetirizine is a second-generation antihistamine that works by selectively antagonizing H1 receptors, thereby preventing the symptoms of allergic reactions. Montelukast is a leukotriene receptor antagonist that blocks cysteinyl leukotriene receptors (CysLT1) in the lungs and bronchial tubes, reducing inflammation and relaxing airway muscles. This dual-action approach provides comprehensive relief from both allergic symptoms and airway constriction.

Brand names

Lazaz-M

Other names

Levocetirizine + Montelukast